Skilled partners in the conduct of HIV prevention trials join COVID-19 response
Coronavirus Shakes Markets—Likely Temporarily
COVID-19: Science and Economics
FDA issues two guidances to accelerate Covid-19 treatments
Merck CPO Julie Gerberding On The Deadliness Of Covid-19
Gilead’s Remdesivir Will Be Distributed By State Health Departments
NIH clinical trial tests Remdesivir plus anti-inflammatory drug Baricitinib for COVID-19
NIH kicks off combo study on the impact of Eli Lilly’s Olumiant on Covid-19 cases — using a dose rejected as too dangerous for RA
Capricor (CAPR) Shares Could Hit $10, Says Analyst
UPDATED: FDA cheers on Gilead's remdesivir with a snap emergency OK, giving biopharma a shot at redemption
Gilead’s Remdesivir Receives Emergency FDA Approval; Here's What This Five-Star Analyst Has To Say
Clinical trial to investigate whether hypertension drug ameliorates COVID-19 severity
Blood clotting a significant cause of death in patients with COVID-19
A new way to accurately estimate COVID-19 death toll